Published in Cancer Res on June 01, 1999
Mechanism of active renal tubular efflux of tenofovir. Antimicrob Agents Chemother (2006) 2.41
T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias. Leuk Lymphoma (2011) 2.37
Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci U S A (2000) 1.83
Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial. J Clin Oncol (2011) 1.60
Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis? Ann Rheum Dis (2003) 1.59
MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A (1999) 1.59
Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics. J Clin Invest (2005) 1.46
Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br J Cancer (2000) 1.43
The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch (2006) 1.40
In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile. PLoS Med (2008) 1.37
ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res (2005) 1.37
ABCC10, ABCC11, and ABCC12. Pflugers Arch (2006) 1.34
MRP subfamily transporters and resistance to anticancer agents. J Bioenerg Biomembr (2001) 1.24
Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha. Ann Rheum Dis (2004) 1.13
Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1). Pflugers Arch (2006) 1.11
ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut (2003) 1.10
Multidrug resistance associated proteins in multidrug resistance. Chin J Cancer (2011) 1.08
The effect of rifampin treatment on intestinal expression of human MRP transporters. Am J Pathol (2000) 1.04
Polymorphism in PfMRP1 (Plasmodium falciparum multidrug resistance protein 1) amino acid 1466 associated with resistance to sulfadoxine-pyrimethamine treatment. Antimicrob Agents Chemother (2009) 1.01
Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer. Parasitol Res (2008) 1.00
ABC proteins of Leishmania. J Bioenerg Biomembr (2001) 1.00
A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport. Biochem J (2003) 1.00
Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem J (2002) 0.99
Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARDs. Ann Rheum Dis (2004) 0.97
Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice. J Virol Methods (2012) 0.96
Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport. Br J Pharmacol (2000) 0.96
Nrf2 pathway regulates multidrug-resistance-associated protein 1 in small cell lung cancer. PLoS One (2013) 0.96
MRP3: a molecular target for human glioblastoma multiforme immunotherapy. BMC Cancer (2010) 0.96
Chemosensitization of Plasmodium falciparum by probenecid in vitro. Antimicrob Agents Chemother (2003) 0.94
Genetic and epigenomic footprints of folate. Prog Mol Biol Transl Sci (2012) 0.93
The ank gene story. Arthritis Res (2000) 0.89
Pharmacogenetics in acute lymphoblastic leukemia. Semin Hematol (2009) 0.88
Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 0.86
Expression of multidrug resistance-1 protein correlates with disease activity rather than the refractoriness to methotrexate therapy in rheumatoid arthritis. Clin Rheumatol (2009) 0.84
Lamellarin O, a pyrrole alkaloid from an Australian marine sponge, Ianthella sp., reverses BCRP mediated drug resistance in cancer cells. Mar Drugs (2014) 0.84
Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer. BMC Cancer (2013) 0.83
Characterisation of exogenous folate transport in Plasmodium falciparum. Mol Biochem Parasitol (2007) 0.83
Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug. Ann Rheum Dis (2006) 0.82
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs? BMC Med (2013) 0.82
Localization of multidrug resistance-associated protein 2 in the nonpigmented ciliary epithelium of the eye. J Pharmacol Exp Ther (2009) 0.81
The use of Tris-lipidation to modify drug cytotoxicity in multidrug resistant cells expressing P-glycoprotein or MRP1. Br J Pharmacol (2002) 0.80
Endocrine and metabolic regulation of renal drug transporters. J Biochem Mol Toxicol (2012) 0.80
Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model. Antimicrob Agents Chemother (2013) 0.80
Functional regulation of P-glycoprotein at the blood-brain barrier in proton-coupled folate transporter (PCFT) mutant mice. FASEB J (2012) 0.79
Design, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors. Bioorg Med Chem (2011) 0.79
Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia. J Hematol Oncol (2015) 0.78
Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabine. Springerplus (2014) 0.77
Exploring the structure-activity relationships of ABCC2 modulators using a screening approach. Bioorg Med Chem (2015) 0.77
Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia. Int J Nanomedicine (2016) 0.76
Effects of 3β-acethyl tormentic acid (3ATA) on ABCC proteins activity. Int J Mol Sci (2012) 0.76
A structure-activity relationship study of ABCC2 inhibitors. Eur J Pharm Sci (2017) 0.75
Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor. Brain Res Bull (2009) 0.75
MDR-1 and MRP-1 activity in peripheral blood leukocytes of rheumatoid arthritis patients. Diagn Pathol (2015) 0.75
Renal Drug Transporters and Drug Interactions. Clin Pharmacokinet (2017) 0.75
The gel electrophoresis of DNA. Biochim Biophys Acta (1972) 11.85
A freeze-squeeze method for recovering long DNA from agarose gels. Anal Biochem (1975) 11.28
Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science (1992) 9.32
Discontinuous transcription and antigenic variation in trypanosomes. Annu Rev Biochem (1986) 5.60
Renaturation of mitochondrial DNA. Biochim Biophys Acta (1966) 4.79
Mitochondrial DNA from sheep heart. Proc Natl Acad Sci U S A (1966) 4.65
Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature (1992) 4.45
Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature (1992) 4.44
Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst (2001) 4.27
Mitochondrial nucleic acids. Annu Rev Biochem (1972) 4.25
Programmed gene rearrangements altering gene expression. Science (1987) 4.12
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res (2001) 4.05
Antigenic variation in Trypanosoma brucei analyzed by electrophoretic separation of chromosome-sized DNA molecules. Cell (1984) 4.03
A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst (2000) 3.98
The mitochondrial genome of yeast. Cell (1978) 3.84
Molecular basis for trypanosome antigenic variation. Cell (1982) 3.80
Mitochondrial DNA. V. A 25 micron closed circular duplex DNA molecule in wild-type yeast mitochondria. Stucture and genetic complexity. Biochim Biophys Acta (1970) 3.67
Activation of trypanosome surface glycoprotein genes involves a duplication-transposition leading to an altered 3' end. Cell (1981) 3.65
Three small RNAs within the 10 kb trypanosome rRNA transcription unit are analogous to domain VII of other eukaryotic 28S rRNAs. Nucleic Acids Res (1986) 3.30
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet (1999) 3.25
Structure of the growing telomeres of Trypanosomes. Cell (1984) 3.24
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci U S A (1997) 3.20
Growth of chromosome ends in multiplying trypanosomes. Nature (1983) 3.16
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest (1995) 3.13
Gel electrophoresis of RNA under denaturing conditions. Biochim Biophys Acta (1973) 3.05
The isolation of plasmids containing DNA complementary to messenger RNA for variant surface glycoproteins of Trypanosoma brucei. Gene (1980) 2.99
Inactivation of transcription by UV irradiation of T. brucei provides evidence for a multicistronic transcription unit including a VSG gene. Cell (1987) 2.93
Targeted insertion of the neomycin phosphotransferase gene into the tubulin gene cluster of Trypanosoma brucei. Nature (1990) 2.91
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci U S A (1997) 2.91
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol (1989) 2.89
Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet (2000) 2.89
MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell (1996) 2.87
RNA splicing is required to make the messenger RNA for a variant surface antigen in trypanosomes. Nucleic Acids Res (1982) 2.87
Nucleotide sequence of the mitochondrial structural gene for subunit 9 of yeast ATPase complex. Proc Natl Acad Sci U S A (1979) 2.83
The drug resistance-related protein LRP is the human major vault protein. Nat Med (1995) 2.78
Reversible thyroid dysfunction during treatment with GM-CSF. Lancet (1991) 2.77
Genomic environment of the expression-linked extra copies of genes for surface antigens of Trypanosoma brucei resembles the end of a chromosome. Nature (1982) 2.75
Alpha-amanitin-insensitive transcription of variant surface glycoprotein genes provides further evidence for discontinuous transcription in trypanosomes. Nucleic Acids Res (1984) 2.74
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci U S A (1994) 2.71
Tandem repetition of the 5' mini-exon of variant surface glycoprotein genes: a multiple promoter for VSG gene transcription? Cell (1983) 2.67
Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res (1997) 2.67
The anatomy and transcription of a telomeric expression site for variant-specific surface antigens in T. brucei. Cell (1987) 2.63
Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors. J Clin Oncol (2000) 2.60
Overexpression and amplification of five genes in a multidrug-resistant Chinese hamster ovary cell line. Mol Cell Biol (1986) 2.59
Discontinuous synthesis of mRNA in trypanosomes. EMBO J (1984) 2.57
Chromosome rearrangements in Trypanosoma brucei. Cell (1984) 2.56
An insert in the single gene for the large ribosomal RNA in yeast mitochondrial DNA. Nature (1978) 2.53
Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci U S A (1994) 2.52
Novel expression-linked copies of the genes for variant surface antigens in trypanosomes. Nature (1980) 2.51
Hypermodified bases in DNA. FASEB J (1995) 2.49
Localization of nine glycolytic enzymes in a microbody-like organelle in Trypanosoma brucei: the glycosome. FEBS Lett (1977) 2.44
The organization of ribosomal RNA genes in the mitochondrial DNA of Tetrahymena pyriformis strain ST. Biochim Biophys Acta (1978) 2.42
The promoter for a variant surface glycoprotein gene expression site in Trypanosoma brucei. EMBO J (1990) 2.41
Comparison of the genes coding for the common 5' terminal sequence of messenger RNAs in three trypanosome species. Nucleic Acids Res (1984) 2.40
Doxorubicin gradients in human breast cancer. Clin Cancer Res (1999) 2.36
Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science (1996) 2.35
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer (2002) 2.34
Functional analysis of 150 deletion mutants in Saccharomyces cerevisiae by a systematic approach. Mol Gen Genet (1999) 2.26
Kinetoplast DNA. Plasmid (1979) 2.20
An analysis of cosmid clones of nuclear DNA from Trypanosoma brucei shows that the genes for variant surface glycoproteins are clustered in the genome. Nucleic Acids Res (1982) 2.16
Many trypanosome messenger RNAs share a common 5' terminal sequence. Nucleic Acids Res (1984) 2.11
How proteins get into microbodies (peroxisomes, glyoxysomes, glycosomes). Biochim Biophys Acta (1986) 2.08
Isolation and characterization of kinetoplast DNA from bloodstream form of Trypanosoma brucei. J Cell Biol (1978) 2.06
Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci U S A (1995) 2.00
beta-D-glucosyl-hydroxymethyluracil: a novel modified base present in the DNA of the parasitic protozoan T. brucei. Cell (1993) 2.00
Mitochondrial DNA: physicochemical properties, replication, and genetic function. Int Rev Cytol (1969) 1.99
Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res (1993) 1.99
The transposition unit of variant surface glycoprotein gene 118 of Trypanosoma brucei. Presence of repeated elements at its border and absence of promoter-associated sequences. J Mol Biol (1983) 1.98
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta (2002) 1.98
Mature mRNAs of Trypanosoma brucei possess a 5' cap acquired by discontinuous RNA synthesis. Nucleic Acids Res (1985) 1.97
Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol (2001) 1.94
Activation of the genes for variant surface glycoproteins 117 and 118 in Trypanosoma brucei. J Mol Biol (1983) 1.91
A new method for fluorescence microscopical localization of specific DNA sequences by in situ hybridization of fluorochromelabelled RNA. Exp Cell Res (1980) 1.91
One gene's intron is another gene's exon. Nature (1981) 1.90
In vivo labelling of intermediates in the discontinuous synthesis of mRNAs in Trypanosoma brucei. EMBO J (1987) 1.87
Circular mitochondrial DNA. Biochim Biophys Acta (1966) 1.86
Tissue distribution of the multidrug resistance protein. Am J Pathol (1996) 1.84
Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci U S A (2000) 1.83
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res (1996) 1.82
Variant surface glycoproteins of Trypanosoma brucei are synthesised with cleavable hydrophobic sequences at the carboxy and amino termini. Nucleic Acids Res (1981) 1.82
On the DNA content and ploidy of trypanosomes. Mol Biochem Parasitol (1982) 1.82
Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res (1993) 1.81
The major transcripts of the kinetoplast DNA of Trypanosoma brucei are very small ribosomal RNAs. Nucleic Acids Res (1983) 1.81
Further characterization of the extremely small mitochondrial ribosomal RNAs from trypanosomes: a detailed comparison of the 9S and 12S RNAs from Crithidia fasciculata and Trypanosoma brucei with rRNAs from other organisms. Nucleic Acids Res (1985) 1.81
HA-966 effects on striatal dopamine metabolism: implications for dopamine compartmentalization. J Pharm Pharmacol (1980) 1.80
A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology (1997) 1.79